SINOPHARM GRP CO UNSP/ADR by Sinopharm Group Co. Ltd. Financials - Benzinga

SINOPHARM GRP CO UNSP/ADR by Sinopharm Group Co. Ltd.

SHTDYOTCPK

Trade with Public

Trade with Public

$9.44

-0.02-0.21%

At close: Sep 18, 5:00 PM EST

Overview NewsFinancialsSentiment Ownership Compare

SINOPHARM GRP CO UNSP/ADR by Sinopharm Group Co. Ltd. Financials

SINOPHARM GRP CO UNSP/ADR by Sinopharm Group Co. Ltd. (SHTDY) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Current Updates On COVID-19 Vaccines

Besides saving lives and the global economy, we are expecting three things from the upcoming COVID-19 vaccine: safety, immunogenicity and efficacy. But we never had a 100 percent efficacy when it comes to respiratory viruses, so anything between 50 and 100% will be the best we've got as the WHO believes everything above 50 percent efficacy is acceptable.

IAM Newswire